Interview: Gilead's Daniel O'Day on new medicines, winning the Covid battle and the search for cancer cures
Gilead Sciences
Docklands site will run clinical trials for paediatric versions of current and future drugs
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Shareholder proposal demands pharma group open up Covid-19 vaccine tech to poorer countries
The loss last year followed a pre-tax profit of $288.4m in 2019
Mucormycosis cases soar to 30,000 from negligible levels within three weeks
Company seeking alternative roles for staff after loss of contract with Gilead Sciences
Company said the Covid-19 pandemic continues to affect its sales, but growth expected
World round-up: India’s daily rise in cases stays below 40,000 for fourth day
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times